Clinical trial
Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
NCT04259255 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
- Lead sponsor
- Shionogi
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 21, 2019
- Completion date
- November 24, 2024
- Enrollment
- 74 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.